BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37017854)

  • 1. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.
    Xia X; Zhao S; Chen W; Xu C; Zhao D
    Ir J Med Sci; 2023 Dec; 192(6):2653-2660. PubMed ID: 37017854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC.
    Li H; Wang S; Li X; Weng Y; Guo D; Kong P; Cheng C; Wang Y; Zhang L; Cheng X; Cui Y
    Cancer Sci; 2023 Jan; 114(1):91-104. PubMed ID: 36056599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.
    Wu Y; Liu Q; Yan X; Kato Y; Tanaka M; Inokuchi S; Yoshizawa T; Morohashi S; Kijima H
    Int J Oncol; 2016 Jun; 48(6):2310-20. PubMed ID: 27035755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
    Iguchi T; Ueda M; Masuda T; Nambara S; Kidogami S; Komatsu H; Sato K; Tobo T; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Oncology; 2018; 95(3):179-187. PubMed ID: 29909415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
    Yang HJ; Liu GL; Liu B; Liu T
    J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
    Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
    Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
    BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling.
    Zhang X; Xu C; Wang C; Pei Y; He M; Wan Z; Hou J; Wang L
    Clin Exp Metastasis; 2024 Apr; 41(2):81-90. PubMed ID: 38396262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
    Matsushima K; Isomoto H; Yamaguchi N; Inoue N; Machida H; Nakayama T; Hayashi T; Kunizaki M; Hidaka S; Nagayasu T; Nakashima M; Ujifuku K; Mitsutake N; Ohtsuru A; Yamashita S; Korpal M; Kang Y; Gregory PA; Goodall GJ; Kohno S; Nakao K
    J Transl Med; 2011 Mar; 9():30. PubMed ID: 21426561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dihydromyricetin mediates epithelial mesenchymal transformation and regulates the proliferation and apoptosis of esophageal squamous cell carcinoma cells].
    Tian YP; Cui YS; Zheng X; Liu BL; Zhang YP; Wei KP; Zhang Z; Hu WN; Zhang XM; Sun GG
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):326-333. PubMed ID: 35448920
    [No Abstract]   [Full Text] [Related]  

  • 14. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.
    Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X
    Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma.
    Chen Y; Chen Y; Liu W
    Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 17. WISP1 aggravates cell metastatic potential by abrogating TGF-
    Song D; Wang L; Su K; Wu H; Li J
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway.
    Cui Y; Zhang L; Wang W; Ma S; Liu H; Zang X; Zhang Y; Guan F
    Mol Cell Biochem; 2019 Oct; 460(1-2):93-103. PubMed ID: 31278587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.